IQV — Bearish (ASignal Rank 4/4)
ASignal's 10+ AI agent pipeline rates IQV as Bearish with 79% confidence in the Healthcare sector.
AI Analysis Summary
IQV presents significant downside risk due to extreme leverage, weak liquidity, and bearish technicals despite strong cash flow and growth metrics.
Investment Framework Assessment
Evaluated through three legendary investor frameworks:
- Warren Buffett (Value Investing): Grade D — 25/100
- Bill Ackman (Activist Investing): Grade B+ — 68/100
- Ray Dalio (Macro/Risk Parity): Grade D — 42/100
Consensus: Bearish
Price Intelligence
- Current price: $163.84
- Price target: $161.22 (-1.6%)
- Risk level: high
- Horizon: medium term
Quality Assessment
- Balance sheet: concerning
- Cash flow: good
- Competitive moat: none
Peer Group Analysis
IQV is in the “Oversold & Compressed” cluster alongside ZBH, XOM, WFC, WDAY, VLO (128 stocks total). 0 of 128 peers are currently bullish.